Remove 2018 Remove FDA Remove Governance
article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

Experts’ Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care. A New Way to Contain Unaffordable Medication Costs – Exercising the Government’s Existing Rights. Medicaid Expenditures and Estimated Rebates on Line Extension Drugs, 2010-2018. 2022 Feb 24.

FDA 208
article thumbnail

Physician venture investor talks telehealth, digital therapeutics, Medicaid tech

Healthcare It News

Notably, since 2018, mental health has been the top clinical indication to receive investment, growing from $1.4 Companies like Pear Therapeutics, Limbix, Applied VR and Click Therapeutics are treating people with clinically validated and FDA-approved (or pending) digital interventions. billion that year to $5.1

Medicaid 358
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What If Costco Designed the Prescription Drugs Sales Model?

Health Populi

Its longer more formal name was The Drug Price Competition and Patent Term Restoration Act of 1984, and it created a pathway for generic drug applications to the FDA. “Among the 184 most commonly prescribed drugs in Medicare Part D in 2018, 90% could be purchased at Costco for less than $20 for a 30-day supply.”

article thumbnail

Addressing Bias in Healthcare AI: A Guide for Developers and Clinicians

HIT Consultant

But with that promise comes the responsibility of understanding and applying governance, ethical, and reliability principles. The AI might misinterpret images from patients with darker skin tones and fail to diagnose melanoma due to sampling bias (Adamson & Smith, 2018). Regulatory Guidance Oversight by the U.S.

FDA 105
article thumbnail

The FDA Ramps Up GMP Inspections

Dot Compliance

Prior to the COVID-19 pandemic, during fiscal year (FY) 2019 (October 1, 2018, through September 30, 2019), the FDA conducted 7,266 GMP inspections of registered drug, device and biologics establishments. Compliance Dashboard, Inspections, FDA, accessed October 3, 2022, [link] cd/inspections.htm ).

FDA 52
article thumbnail

The Government Seeks FCA Liability for Off-Label Use of Medical Devices

Healthcare Law Blog

is a reminder that the government will use the FCA to target medical device manufacturers for off-label use of medical devices, even where healthcare providers have decided the use is safe and effective. The FDA even required warnings on the probes’ packaging, “restricted for single person use only,” and “[d]o not re-use.”.

article thumbnail

Moving at the speed of Eugene Borukhovich, Bayer’s Global Head of Digital Health Innovation — Harlow On Healthcare

Health Blawg

Eugene and his team are just getting this off the ground (Summer 2018). Eugene and his team are just getting this off the ground (Summer 2018). Everyone loves change, but nobody wants to change.”. Join the conversation on Twitter at #HarlowOnHC. David Harlow. The Harlow Group LLC. Health Care Law and Consulting.

FDA 113